You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Universal Plasma Generator for Selective Removal of Anti-A and Anti-B Antibodies from Donor Plasma
SBC: LYNNTECH INC Topic: DHP15B001Traumatic injury accounts for 14.2% of all fatalities. Clinical management of trauma often requires massive plasma transfusions. However, in critical combat casualty care or in civilian emergency trauma care, plasma of compatible blood group may not be readily available. Transfusion with incompatible plasma may result in potentially fatal hemagglutination in the recipient. Typeless or universal pl ...
STTR Phase II 2017 Department of DefenseDefense Health Agency -
Innovative Wound Regeneration Support Approaches to Enable Rapid Treatment of Wounded Warfighters
SBC: Zetroz Systems LLC Topic: A14AT016Ultrasound is a therapeutic modality which has been used clinically for 60 years, but has been limited in practice by the complexity of the technology. Recent research has allowed for the development of a portable, wearable, long duration, low intensity therapeutic ultrasound system. The system is powered by battery, and can be applied by a user to deliver up
STTR Phase II 2016 Department of DefenseDefense Health Agency -
Use of Highly Porous Polymer Beads to Remove Anti-A and Anti-B Antibodies from Plasma for Transfusion
SBC: CYTOSORBENTS MEDICAL INC Topic: DHP15B001Plasma from AB donors is considered universal as it can be transfused regardless of recipient blood type and is frequently used to rapidly resuscitate massively bleeding hospital trauma patients and warfighters with combat casualties. However supplies can be rapidly depleted as AB donors make up only 4% of the population. Therefore robust a technology to cost-effectively generate universal plasma ...
STTR Phase II 2017 Department of DefenseDefense Health Agency -
Production of Chemical Reagents for Prompt-Agent-Defeat Weapons
SBC: NALAS ENGINEERING SERVICES INC Topic: DTRA14B001Nalas Engineering and Johns Hopkins University collaborated in a Phase I STTR program to study reactive mixtures of HI3O8 and nanocomposite fuels previously developed by the Weihs Group. These fuel/oxidizer mixtures are uniquely able to simultaneously produce heat and biocidal iodine gas, a combination designed to destroy biological weapons. The team at Nalas focused on evaluating conditions for p ...
STTR Phase II 2017 Department of DefenseDefense Threat Reduction Agency